✦ LIBER ✦

PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes

✍ Scribed by Qin, Ya-Zhen; Zhu, Hong-Hu; Liu, Yan-Rong; Wang, Ya-Zhe; Shi, Hong-Xia; Lai, Yue-Yun; Xu, Lan-Ping; Liu, Dai-Hong; Jiang, Qian; Li, Ling-Di; Jiang, Bin; Liu, Kai-Yan; Huang, Xiao-Jun

Book ID: 118177640
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 407 KB
Volume: 54
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2012.743656

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

WT1 gene expression: useful marker for m

WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?

✍ Peter Bader; Charlotte Niemeyer; Gerrit Weber; Tiziana Coliva; Vincenzo Rossi; H 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

WT1 as a Universal Marker for Minimal Re

WT1 as a Universal Marker for Minimal Residual Disease Detection and Quantification in Myeloid Leukemias and in Myelodysplastic Syndrome

✍ Cilloni, Daniela; Saglio, Giuseppe 📂 Article 📅 2004 🏛 S. Karger AG 🌐 English ⚖ 87 KB

NPM1 mutation is a stable marker for min

NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression

✍ Thomas Kristensen; Michael B. Møller; Lone Friis; Olav J. Bergmann; Birgitte Pre 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB

Quantitative monitoring of cyclin D1 exp

Quantitative monitoring of cyclin D1 expression: A molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma

✍ Helena Brizova; Marketa Kalinova; Lenka Krskova; Marcela Mrhalova; Roman Kodet 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 235 KB

## Abstract In mantle cell lymphoma (MCL), minimal residual disease (MRD) is an indicator of the disease outcome. Quantitative methods used so far do not provide a suitable molecular marker in 30–70% patients with MCL (depending on the technique used). We tested cyclin D1 as a marker for quantitati

Molecular Detection of TEL-AML1 Transcri

Molecular Detection of TEL-AML1 Transcripts as a Diagnostic Tool and for Monitoring of Minimal Residual Disease in B-lineage Childhood Acute Lymphoblastic Leukemia

✍ Hyeon Jin Park; Kyeong Eun Lee; Jung Min Um; Soo Young Choe; Xin Zi Chi; Jun Ah 📂 Article 📅 2000 🏛 Korean Society for Molecular and Cellular Biology 🌐 English ⚖ 80 KB